Position in GRAL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,944,571
+$893,179 QoQ
Shares Held
57,779
-2.1% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#56
of 374 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Rockefeller Capital Management L.P. holds $423,622,965 across 29 Diagnostics & Research names. GRAL ranks #13 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
426,025 | $213,591,890 | |
| 2 | DHR |
Danaher Corp /De/
|
330,005 | $62,859,350 | |
| 3 | RDNT |
RadNet, Inc.
|
757,990 | $46,745,242 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
51,299 | $27,005,843 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
11,634 | $14,862,548 | |
| 6 | WGS |
GeneDx Holdings Corp.
|
151,164 | $10,377,407 | |
| 7 | ILMN |
Illumina, Inc.
|
51,929 | $9,130,674 | |
| 8 | A |
Agilent Technologies, Inc.
|
58,592 | $7,782,774 |
All Filings in GRAL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,944,571 | 57,779 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,051,392 | 59,044 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $5,869,504 | 68,577 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $3,430,249 | 58,012 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,835,691 | 94,043 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,223,384 | 87,055 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,489,878 | 139,489 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,817,681 | 132,099 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $462,636 | 30,100 | Shares | Defined | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||